Importance of anglogenic action of anglotensin II in the glomerular growth of maturing kidneys. We studied the effect of three antihypertensive drugs on the growth of glomeruli in four-to five-week-old , which were undergoing rapid maturation processes. Young rats were given an angiotensin converting enzyme inhibitor (ACE!, enalapril, 50 mg/liter drinking water), verapamil (50 mg/liter) or hydralazine (80 mg/liter) or no treatment for six weeks. Body weight increased comparably in the treatment groups and agematched controls, reaching on average 197 11, 214 12 and 198 3 g in ACE!-, verapamil-and hydralazine-treated rats, respectively, versus 218 6 g in control rats. Glomerular hemodynamic patterns, including glomerular capillary pressure, measured in maturing rats after one and six weeks of ACE! treatment were unaffected by ACE!. Mean planar area of glomeruli (PAmean) achieved was smaller than control in ACE! rats (6.60 0.20 x l0mm2 vs. 5.37 0.22, respectively, P < 0.005), but not in rats treated with other antihypertensive drugs.
© 1990 by the International Society of Nephrology [7] , and most recent preliminary in vitro studies using glomerular cells have also shown angiogenic potential of angiotensin II in the glomerulus [8] . It has therefore been postulated that endogenous angiotensin II may play a role in the development of glomerular hypertrophy in some in situ settings, at least in part, through mechanism(s) independent of its well known effect on glomerular hemodynamics. In designing our studies assessing the effect of ACEI on the structure and hemodynamics of the maturing glomeruli, in which a rapid angiogenic process is taking place, we speculated that the angiogenic effect of angiotensin II may be distinguished from its hemodynamic effect in these otherwise normal healthy animals [9, 10] .
Methods
Studies were performed in twenty-four, four-to five-weekold and twelve more than three-month-old male Munich-Wistar rats. Animals were allowed free access to regular rat chow and tap water. Systolic arterial pressure was measured at six weeks by the tail cuff method [11] in awake animals.
Experimental groups
Experimental protocols employed in the present studies are illustrated in Figure 1 .
Group I: Six week treatment of maturing rats with or without antihypertensives. Four-to five-week-old rats were placed on one of the following antihypertensive drugs for six weeks, right up to the time of micropuncture, as described below. 
Group Id: No antihypertensives (CONT, N 7).
At six weeks Group Ia and Id animals were subjected to the micropuncture assessment of glomerular hemodynamics, followed by the morphometric analysis of glomeruli on fixed kidney tissues as described below. In a separate group of six young rats (Group Ia') given enalapril as above, micropuncture assessment was done after one week of treatment to assess the early hemodynamic pattern with this treatment. Kidneys from four-to five-week old age-matched rats, not shown in Figure 1 (N = 6), were examined morphometrically to determine normal glomerular size at the onset of the study. 
Group 2b: No antihypertensives (N = 6).
A separate group of adult rats (N = 4, >3 months old) was treated with enalapril, 50 mg/liter drinking water as Group 2a, for one week, and plasma renin and angiotensin converting enzyme activities determined to verify that this dose indeed has biologic activity in adult rats. Control rats (N = 4) received no drug. Plasma renin activity was markedly elevated in enalapril treated rats versus control, on average 96 39 versus 25 7 ng/ml, while angiotensin converting enzyme was substantially reduced below normal, on average 7.4 0.1 versus 22.2 0.7 U/liter, respectively (P < 0.0005).
At six weeks animals were sacrificed for the morphometric analysis of glomeruli specified below.
Renal clearance and micropuncture measurements Animals were anesthetized with an intraperitoneal injection of mactin (Byk, Gulden Konstanz, FRG; 100 mg/kg body wt, i.p.), placed on a temperature-regulated micropuncture table, and prepared as previously described [12] . Briefly, following tracheostomy, indwelling polyethylene catheters (PE-50, Clay Adams, Parsippany, New Jersey, USA) were placed into the left and right jugular veins for infusion of plasma, inulin and para-aminohippurate (PAH). The left femoral artery was catheterized to monitor mean systemic arterial pressure (MAP), measured by electronic transducer (Model p23XL, Gould Inc., Cleveland, Ohio, USA) connected to a recorder (Model 2200S, Gould Inc.). The left ureter was cannulated with PE-lO catheter for urine collections. The left kidney was suspended on a Lucite holder, its surface illuminated with a fiberoptic light source, and bathed with 0.9% NaCl. Volume losses consequent to surgical preparation were replaced with plasma, infused in a volume equal to 1% of body weight over 30 minutes, followed by a maintenance infusion at the rate of 1.2 mI/hr. A solution of 10% inulin and 1.0% PAH in 0.9% NaCI was infused throughout the duration of the experiment at the rate of 1.2 mI/hr.
After a 60-minute equilibration period, clearance and micropuncture measurements were made as detailed below. Exactly timed (1 to 2 mm) samples of tubule fluid were collected from surface proximal convolutions for the determinations of flow rate and inulin concentration for calculation of single nephron glomerular filtration rate (SNGFR). Coincident with the tubule fluid collections, femoral arterial blood was obtained for the determination of hematocrit and plasma concentrations of protein, inulin and PAH. Whenever appropriate, two or three samples of urine from the kidney were collected for determinations of flow rate, inulin and PAH concentrations, which were used in the calculation of whole kidney GFR and effective renal plasma flow rate (ERPF).
Hydraulic pressures were monitored in accessible surface structures with a continuous-recording servo-null micropipette transducer system (Model 3, Instrumentation for Physiology and Medicine, San Diego, California, USA). Micropipettes with outer diameter of I to 2 tm containing 2.0 M NaCI were used. Hydraulic output from the servo-null system was converted electronically to a recorder (Model 2200S, Gould) by means of a pressure transducer. Direct measurements of time-averaged hydraulic pressures were recorded in single capillaries of surface glomeruli (PGc), Bowman's space, and surface efferent arteriole. For estimation of oncotic pressures of plasma entering and leaving glomerular capillaries, protein concentrations of afferent (CA) and efferent (CE) arterioles were determined by analyzing femoral arterial and surface efferent arteriolar plasma, respectively, using the fluorometric method previously described [13, 14] .
Histological study Kidneys were immersion fixed in 10% buffered formalin, routinely processed and embedded in paraffin. Sections of 3 j.m thickness were made, stained with periodic acid-Schiff, and examined microscopically (Olympus BH2, Olympus Optical Co. Ltd., Tokyo, Japan).
Mean planaE area of glomeruli was assessed for young and adult on sections of control and the treatment group kidneys at six weeks and on kidneys from normal young rats at baseline (at 0 weeks). The planar area of each glomerular capillary tuft was determined on these sections using a computerized planimeter (Micro-plan II, Monsanto Corp., Natick, Massachusetts, USA) and traced at '-380x magnification using a camera lucida attachment. The Outline of the entire glomerular corpuscle was measured. Extreme tangential cuts of glomeruli, as evidenced by a section showing only discontinuous, separate capillary loops, were excluded. The values of these planar areas, thus measured in 50 to 60 glomeruli, were averaged for each thin section specimen. Analytic The volume of fluid collected from individual proximal tubules by micropuncture was estimated from the length of the fluid column in a constant-bore capillary tube of known internal diameter. Plasma and urine inulin concentrations were assayed by the macroanthrone method of FUhr, Kaczmarczyk and KrOttgen [15] . Inulin concentrations in tubule fluid was determined by the method of Vurek and Pegram [16] . PAH concentration in plasma and urine was measured by the method of Bratton and Marshall, as modified by Smith et al [17] .
Statistical analysis
Results are expressed as mean 1 SEM. Comparisons between two groups were made using the unpaired t-test. Data from multiple groups were compared using one-way ANOVA followed by multiple comparisons by the Bonferroni method [18] . The results were deemed statistically significant when the P value was <0.05.
Results

Systemic and whole kidney parameters
Data for body weight and dry and wet kidney weight measured at the completion of study are shown in Table 1 . Thus, Group Ia, Ib, Ic and Id maturing animals were statistically indistinguishable in body weight regardless of the treatment given during the preceding six week period, Wet kidney weight was significantly less than control only for Group la, whereas dry kidney weight was significantly less in all the treated rats versus control. Group 2a adult animals given ACE! and Group 2b adult control animals were comparable with regards to body and kidney weight. Systemic systolic blood pressure at six weeks was similar between Groups la, lb and id (110 6mm Hg, 113 5, and 109 6, respectively), whereas Group Ic had higher level versus control Group ld and ACE! Group Ia (123 1 mm Hg, P < 0.0005 vs. Group Id, P < 0.005 vs. Group la). Systemic blood pressure in Group 2A adult ACE! was normal (119 5mm Hg).
Whole kidney and glomerular hemodynamic parameters
Average values for several pertinent whole kidney and gbmerular hemodynamic parameters measured in maturing rats of Groups Ia and id are summarized in Table 2 . Thus, values for mean systemic arterial pressure, MAP, were modestly but significantly lower in Group la animals given ACEI than Group ld control rats of the same age, on average by 12 mm Hg. Like those for whole kidney GFR and ERPF, mean values for SNGFR and SNFF were comparable in Group Ia ACE! rats (29.7 2.1 nI/mm and 0.23 0.02, respectively) and Group Id control rats (31.6 1.7 nI/mm and 0.24 0.01, respectively) so that QA values were calculated to be also comparable between the two groups. Values for other gbomerular microcirculatory parameters were also comparable between Group la ACE! and Group Id control rats, demonstrating the typical patterns seen in rats of Munich-Wistar strain at their age [10, 19] . Thus, in Groups Ia and Id values for PGC averaged 51.1 1.3 and 48.7 0.5 mm Hg, respectively. Values of arterial plasma protein concentration, CA, were similar (Table 2) . Likewise, values for affererit and efferent arteriolar resistances were comparable between the two groups. As shown in Table 3 , values for body weight, mean systemic arterial pressure and P0 in Group Ia' rats after one week of enalapril showed patterns indistinguishable from those measured in age-matched rats previously reported by us [10] . Exception to these resemblances in glomerular microcirculatory dynamics between the ACEI-treated and untreated maturing rats was the value of glomerular capillary ultrafiltration coefficient, K. Thus, values for K in Group Ia Values are expressed as mean ± SEM. MAP, Mean arterial pressure; GFR, whole kidney glomerular filtration rate; ERPF, effective renal plasma flow rate; SNGFR, single nephron glomerular filtration rate; QA glomerular plasma flow rate; SNFF, single nephron filtration fraction; POC, glomerular capillary hydraulic pressure; RA, afferent arteriolar resistance; RE, efferent arteriolar resistance; CA, systemic arterial plasma protein concentration; Kr, glomerular capillary ultrafiltration coefficient; ACE!, angiotensin converting enzyme inhibitor, enalapril; No-Tx, control rats not given antihypertensives; NS, P 0.05. Filtration pressure equilibrium was achieved in 2 ACE! rats and 3 No-Tx rats.
a Unique and minimum Kf values were pooled to obtain these average values. rats given ACE! for six weeks averaged 0.057 ± 0.008 nIl (sec mm Hg), a value 27% below the average value measured in age-matched Group ld control rats (0.078 ± 0.008, P < 0.05). Figure 2 summarizes values for PAmean determined at the completion of study in all experimental groups. Baseline PAmean at 0 weeks in young rats was 4.16 ± 0.24 X 103mm2 ( Fig. 2A, horizontal line) . Not surprisingly, all young rats showed continued growth after six weeks. Values for PAmean were smaller, but approached the adult size, in Group ld control maturing ( Fig. 2A) versus Group 2b control adult rats (Fig. 2B) , on average 6.60 ± 0.20 x 103mm2 versus 6.98 ± 0.33, respectively. Of note, within Group 1 maturing animals, but not in the adult, there was a significant difference in PAmean among subgroups given different treatment ( Fig. 2A) . Thus, PAmean averaged 5.37 ± 0.22 x 103mm2, 6.32 ± 0.26, 6.37 ± 0.09 and 6.60 ± 0.20, respectively, in Group la (ACE!), lb (VPL), Ic (HLZ) and ld (No-Tx) maturing rats. Thus, glomerular growth of Group lb VPL and Group lc HLZ rats was comparable to Group ld control maturing rats, with increases of 52%, 53% and 59% over 0 week baseline values, respectively. In contrast, Group la rats given ACE! had significantly smaller PAmean (P < 0.005 ACE! vs. No-Tx; P < 0.025 ACE! vs. VPL or HLZ) and showed only half of the growth observed in the other groups (29% increase over baseline PAmean). In adults, by contrast, six weeks of ACEL treatment did not affect glomerular size: PAmean values were comparable between Group 2a and 2b, averaging 7.08 ± 0.22 x 103mm2 versus 6.98 ± 0.33, respectively (P > 0.4).
Glomerular morphology
Discussion
The renin-angiotensin system is active during intrauterine life, and remains so in the neonate of several mammalian species as compared to the adult [20] [21] [22] . Physiological role for this active renin-angiotensin system during the early periods of life, however, has not been elucidated [23] . In fact, the finding of Jose et al [9] that the prevailing level of RBF in young animals did not increase after antagonism of angiotensin II was taken to indicate that this hormone does not participate in determining the high renal arteriolar vascular tone characterizing young Animals. Evidence that the same notion applies also to the five-to six-week-old maturing rats in the present study has recently been obtained in a series of experiments conducted by us and others. Both plasma renin activities [10] and angiotensin II concentrations [24] were shown to reach similarly low levels as those of adults by five to six weeks of age. Yet, in response to a given amount of exogenous angiotensin II, vasoconstrictive response of young animals is remarkably less than that of adults [10, 25] . In contrast to the lack of evidence of vasoconstrictive action of angiotensin I! in maturing animals, recent studies suggest that angiotensin may have an important role in the growth and differentiation in the young animal. In this regard, angiotensin I! receptors are highly expressed in the rat fetus [5] . Studies of the augmented expression of renin mRNA found maximal levels at the time of most marked nephrogenesis in the newborn rat [6]. Our observations further point to the importance of angiotensin II in glomerular maturational growth after completion of nephrogenesis in the rat.
Administration of angiotensin I converting enzyme inhibitor in normal adult rats regularly fails to induce alteration in glomerular circulatory dynamics [26, 27] . Therefore we verified that the dose given indeed has biologic effect in the adult rats, by showing inhibition of angiotensin converting enzyme and elevated plasma renin levels in adult rats given ACE!. Given the observations made in our laboratories [10] that the renin- Average increases over this baseline (100%) PAmean were calculated to be 29%, 52%, 53% and 59%, respectively, for ACEI, VPL, HLZ and no treatment (No-TX) control rats.
angiotensin system reaches the adult low level by age approximately five weeks in normal rats, the observed lack in the present study of hemodynamic effect on maturing glomeruli is also not surprising. The only parameter found to be different between these groups was glomerular capillary ultrafiltration coefficient.' Given that glomerular capillary ultrafiltration coefficient is the product of filtering surface area and hydraulic conductivity of the glomerular capillary wall, the observed K1 reducing effect of chronic administration of ACE! is in concert with our histological findings that Group la animals given ACE! had glomerular planar area substantially less than that of Group id rats not given ACE!. This parallelism between Kf and glomerular planar area is reminiscent of our previous findings that chronic feeding of low protein content diet in MunichWistar rats of four to five weeks of age resulted in parallel reduction of K and glomerular planar area when compared to age-matched control animals in the absence of appreciable influence on glomerular capillary pressure 1281. This effect of low protein diet on glomerular size and Kf may be at least in part through modulation of renin-angiotensin system, since it has recently been shown that the dietary protein intake modulates renin mRNA expression 129]. Thus, angiotensin II has both hemodynamic and angiogenic actions, and inhibition of Numerically, P was slightly higher in group Ia ACE! vs. group Id control, 36.6 1.0 vs. 34.5 0.5 (P>0,4), despite lower average value for SNGFR in the former. Since the relationship between SNGFR and its determinants is not a simple linear one, P values for each parameter can vary, as in this study, where P was less than 0.05 for K1 only.
ACE will therefore modify both of these factors: the former hemodynamic effect occurs acutely while the angiogenic action is chronic. Taken together, our studies with chronic ACET suggest that angiotensin II is indeed important in maturing kidneys, specifically, in terms of its role to participate in the growth of glomeruli, which takes place at a rapid rate in these animals.
In contrast to these effects found with ACE!, both VPL and HLZ failed to affect the maturational growth of glomeruli, suggesting that ACEI's suppressive effect on the glomerular growth is not shared with other antihypertensive drugs which are structurally unrelated to ACE!. In fact, glomerular planar area of HLZ rats, relative to their slightly smaller dry kidney weight, was on average even higher than that of control treated rats. In view of the well-known effect of HLZ to activate the renin-angiotensin system [301, our findings with HLZ are further supportive of the notion that angiotensin II is involved in maturational growth. Nevertheless, one may argue that ii higher dosages of VPL and HLZ were given to the maturing animals, they, too, may have caused similar retardation in glomerular growth.
We are, however, intrigued by another possibility which is also consistent with the contention that the physiological significance of angiotensin II in maturing kidneys resides primarily in its angiogenic rather than vasoconstrictive action. The readers may recall that the two final functional expressions of angiotensin H's actions, that is, vasoconstriction and angiogenesis, share common receptor and immediate post-receptor signal transduction processes, yet the intermediary metabolites directly linked to vasoconstriction and angiogenesis are believed to be different beyond the hydrolysis of phosphatidylinositol bisphosphate (PIP2). Thus, the immediate products of PIP2 that is, inositol I ,4,5-trisphosphate (1P3) and diacylglycerol (DAG), are believed to be linked to contraction and angiogenesis, respectively [7] . It is therefore conceivable that unlike immature animals, local level of angiotensin II in baseline condition of adult animals is extremely low, or that normal mature animals lack the post-DAG processes which lead to glomerular growth.
1P3, the other product of PIP2 leads to mobilization of calcium from both intracellular and extracellular sources. Hydralazine and verapamil's [31] vasodilatory actions are channeled through their capacity to interfere with these processes, which are crucial steps for the initial and sustained contractility of the smooth muscle cells, respectively. Therefore it is conceivable that angiogenic actions of angiotensin II, and potentially other growth promoting substances, which are in part independent of this intracellular calcium transfer, may remain intact during the administration of VPL or HLZ. In support of this notion prenatal and postnatal hydralazine treatment was found not to prevent renal vessel wall thickening in genetically spontaneously hypertensive rats despite its effectiveness to ameliorate the characteristic hypertension [32] . Verapamil administration, in a certain dosage, in subtotally nephrectomized rats was actually found to augment glomerular deterioration characteristic of remnant nephrons 133]. In contrast, converting enzyme inhibitor (captopril) in one-kidney one-clip hypertensive rats resulted in decreased arteriolar cross-sectional wall area and also a decrease in the number of small arterioles, although ACEL was without effect on the systemic hypertension. Similar results were seen in ACEI-treated normal rats, indicating that ACE! resulted in inhibition of vascular growth independent of effects on hypertension [34] . Experiments in a rat model of hypertensive cardiac hypertrophy comparing dihydralazine, the calcium antagonist nifedipine and the ACE! ramipril in equipotent antihypertensive dosages, found that only the ACEI prevented and also caused regression of the cardiac hypertrophy.
Even lower, non-antihypertensive doses of the ACE! were effective in this regard, further indicating the role of angiotensin II in vascular growth separate from its vasoconstrictive effects [35] . In another hypertensive animal model, ACE! also reversed the hypertrophy of vascular smooth muscle cells while absolute collagen content remained elevated [36] . This consideration of angiotensin Il-induced vasoconstriction and angiogenesis, which are regulated by different second messengers, raises an interesting possibility that warrants future investigation.
